ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Vaneck Vectors Russia Etf

Vaneck Vectors Russia Etf (0LKM)

21.63
0.00
(0.00%)
Cerrado 01 Marzo 10:30AM

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
21.63
Postura de Compra
0.00
Postura de Venta
0.00
Volume Operado de la Acción
0.00
0.00 Rango del Día 0.00
21.63 Rango de 52 semanas 21.63
Capitalización de Mercado [m]
Precio Anterior
21.63
Precio de Apertura
-
Hora
(O)
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
0.00
Acciones en circulación
95,900,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
8.37
Beneficio por acción (BPA)
0.68
turnover
2.16M
Beneficio neto
64.75M

Acerca de Vaneck Vectors Russia Etf

Sector
Mgmt Invt Offices, Open-end
Industria
Mgmt Invt Offices, Open-end
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
-
Vaneck Vectors Russia Etf is listed in the Mgmt Invt Offices, Open-end sector of the London Stock Exchange with ticker 0LKM. The last closing price for Vaneck Vectors Russia Etf was US$21.63. Over the last year, Vaneck Vectors Russia Etf shares have traded in a share price range of US$ 21.63 to US$ 21.63.

Vaneck Vectors Russia Etf currently has 95,900,000 shares in issue. The market capitalisation of Vaneck Vectors Russia Etf is US$2.07 billion. Vaneck Vectors Russia Etf has a price to earnings ratio (PE ratio) of 8.37.

0LKM Últimas noticias

No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10021.6321.6321.6300DE
40021.6321.6321.6300DE
120021.6321.6321.6300DE
260021.6321.6321.6300DE
520021.6321.6321.6300DE
1560021.6321.6321.6319421.63DE
2600021.6321.6321.63360821.63DE

0LKM - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Vaneck Vectors Russia Etf?
El precio actual de las acciones de Vaneck Vectors Russia Etf es US$ 21.63
¿Cuántas acciones de Vaneck Vectors Russia Etf están en circulación?
Vaneck Vectors Russia Etf tiene 95,900,000 acciones en circulación
¿Cuál es la capitalización de mercado de Vaneck Vectors Russia Etf?
La capitalización de mercado de Vaneck Vectors Russia Etf es USD 2.07B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Vaneck Vectors Russia Etf?
Vaneck Vectors Russia Etf ha negociado en un rango de US$ 21.63 a US$ 21.63 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Vaneck Vectors Russia Etf?
El ratio precio/beneficio de Vaneck Vectors Russia Etf es 8.37
¿Cuál es el ratio de efectivo a ventas de Vaneck Vectors Russia Etf?
El ratio de efectivo a ventas de Vaneck Vectors Russia Etf es 251.11
¿Cuál es la moneda de reporte de Vaneck Vectors Russia Etf?
Vaneck Vectors Russia Etf presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Vaneck Vectors Russia Etf?
El último ingresos anual de Vaneck Vectors Russia Etf es USD 2.16M
¿Cuál es el último beneficio anual de Vaneck Vectors Russia Etf?
El último beneficio anual de Vaneck Vectors Russia Etf es USD 64.75M
¿Cuál es la dirección registrada de Vaneck Vectors Russia Etf?
La dirección registrada de Vaneck Vectors Russia Etf es THE CORPORATION TRUST COMPANY, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de Vaneck Vectors Russia Etf?
La dirección del sitio web de Vaneck Vectors Russia Etf es www.vaneck.com
¿En qué sector industrial opera Vaneck Vectors Russia Etf?
Vaneck Vectors Russia Etf opera en el sector MGMT INVT OFFICES, OPEN-END

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
AMGOAmigo Holdings Plc
0.475p
(72.73%)
11.81M
BEMBeowulf Mining Plc
22.00p
(25.71%)
104.2k
WSGWestminster Group Plc
1.30p
(23.81%)
1.4M
BLOEBlock Energy Plc
1.00p
(21.21%)
11.06M
SMLStrategic Minerals Plc
0.30p
(20.00%)
11.23M
SSTScottish Oriental Smaller Companies Trust Plc
290.00p
(-95.96%)
76.08k
ONCOncimmune Holdings Plc
1.40p
(-43.78%)
1.57M
BMTOBraime Group Plc
1,350.00p
(-20.59%)
547
PYXPyx Resources Limited
1.97p
(-19.76%)
398.74k
MGAMMorgan Advanced Materials Plc
214.50p
(-16.21%)
8.59M
TRPTower Resources Plc
0.0245p
(6.52%)
775.51M
UKOGUk Oil & Gas Plc
0.01125p
(-4.26%)
434.61M
TW.Taylor Wimpey Plc
114.25p
(2.05%)
345.64M
LLOYLloyds Banking Group Plc
72.32p
(0.84%)
344.78M
PREMPremier African Minerals Limited
0.0205p
(-11.26%)
300.49M
Jackxkr Jackxkr 1 minuto hace
Want approval a run then a special dividend for a moass.
NWBO
gerry57 gerry57 2 minutos hace
I have been curious as to why Dr Missliny hasn’t at least explored ALS as an indication for blarcamesine given the time frames of therapeutic effect necessary for a go no go decision. It would require everything he loves a small n and a cheap cost structure with something we all want , treatment the
AVXL
Jetmek_03052 Jetmek_03052 3 minutos hace
You DO know the reason why companies are required to publish financial documents every 3 months...right?

It's specifically so that anyone who decides to invest in a PUBLIC COMPANY can see what that company is doing with their money. How much they are bringing in for revenue, how much
DBMM
Gmenfan Gmenfan 5 minutos hace
All Roads Lead to Obama. He is the Evil “Manchurian Candidate” and Communist Mastermind of Everything Bad That Has Happened to America and President Trump. And I’m a Witness- It All Started at Columbia University

February 26, 2025


By Wayne Allyn Root
Gmenfan Gmenfan 5 minutos hace
All Roads Lead to Obama. He is the Evil “Manchurian Candidate” and Communist Mastermind of Everything Bad That Has Happened to America and President Trump. And I’m a Witness- It All Started at Columbia University

February 26, 2025


By Wayne Allyn Root
SC8 SC8 5 minutos hace
FDA already told MK years ago to have dosimetry worked out before human trials. If it turns out the initial Indian patients were underdosed, it's hard to see FDA not rejecting an IDE application based on that data. Time will tell. If the IDE application gets pushed to 2026, we'll know even MK is
RDGL
$Gambler $Gambler 6 minutos hace
Agreed on all accounts - Powell tends to hold a lot of power, but I think the March 7th crypto meeting may give a few coins the boost they need and I believe we both own them. Trump needs to give the future of crypto a boost and in the same breath he needs to call out Powell to loosen up the cash fl
XRPUSD
Tamboo Tamboo 6 minutos hace
March will be fantastic Lot crypto and GS tickers movements are coming 
GVSI
diamondguru-one diamondguru-one 7 minutos hace
she is...and thank you and 76.............
COOP
Just the facts maam Just the facts maam 7 minutos hace
Silver, I found it interesting that the 10-k incudes exhibit 19.1 Insider Trading Policy. I haven't seen it in previous 10-k filings.
ANIP
zakattack zakattack 7 minutos hace
Again you're the one that pumps a .000001 expert market no bid stock that hasn't moved since 2020 how are you not the troll? You gaslight people into thinking gncp is still active when it's not current you lie you should appologize to everyone if you had any integrity or honor but your scum and you
GNCP
joe botts joe botts 10 minutos hace
It died 3 years ago.
nyt nyt 12 minutos hace
How can you leave Chang out? You're going to give him a complex... He deserves recognition for his dastardly deeds as much as anyone else.
VPLM
Brodey79 Brodey79 12 minutos hace
Honestly it’s probably best for shareholders if they delist and go IPO route. Our shares will be un tradable for a period of time but would get valued right away. Pending they have a good road show and are able to find investors willing to pay the IPO price. With Condor for all to be out I believe
FDCT
beartrap12 beartrap12 14 minutos hace
Seriously Stockfollower??? You want a billionaire who likes to break everything, then buy it for himself getting in the middle of our company when we're almost approved and ready to make money???
Don't go emailing Musk. Look what he did to twitter. Do you really want him taking over our comp
NWBO
GetRichLong GetRichLong 14 minutos hace
Be alerted to any poster on this board making up random revenue numbers and making claims of so called "accumulation" that they can never prove. Don't let your capital get stolen by thieves.
AHRO
J-Bear J-Bear 14 minutos hace

You remind me of Glum....only difference is he was cool and you're just dumb
NCLH
skitahoe skitahoe 14 minutos hace
EX, I believe that DD may very well have it right, but the problem is getting the FDA to agree that what you're trying to import is meeting a need that they'll agree they don't have a treatment for. I believe it would be possible for GBM, but few Doctors are going into battle with the FDA to make s
NWBO
testdaduda testdaduda 16 minutos hace
Diamond Sorry for your lost may your Mother RIP🙏
COOP
ubueltp ubueltp 16 minutos hace
Why was Naz in India? R and D or ……
ELTP
236T568 236T568 17 minutos hace
This is a deep deep red district

https://x.com/Fritschner/status/1895910348882133109?s=19
docj docj 18 minutos hace
Wonder which entity will be the first to want to trial the fibrosis indication using LL? GSK? GILD? PFE? MRK?
PFE
Aero-man Aero-man 18 minutos hace
Bought a nice load of cheap shares this week. Buying when there's "blood in the water".
HALB